Genmab AS (GMAB)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
Return on Assets (%) | 25.973 | 18.639 | 19.545 | 18.352 | 26.224 | 13.144 | 20.115 | 13.275 |
Return on Equity (%) | 28.558 | 19.886 | 20.609 | 19.635 | 28.689 | 14.561 | 22.25 | 14.74 |
Return on Invested Capital (%) | 27.867 | 27.253 | 19.359 | 19.397 | 32.853 | 11.773 | 20.731 | 13.591 |
Operating Margin (%) | 62.244 | 45.088 | 53.3 | 53.41 | 58.491 | 47.112 | 48.345 | 34.381 |
Net Profit Margin (%) | 65.363 | 46.653 | 48.664 | 40.365 | 47.058 | 35.463 | 37.835 | 26.417 |
Book Value Per Share | 76.964 | 100.477 | 122.671 | 208.652 | 286.562 | 333.881 | 413.799 | 476.867 |
Earnings Per Share | 19.67 | 18.036 | 23.938 | 33.285 | 72.59 | 45.771 | 83.715 | 65.865 |
Cash Per Share | 5.087 | 22.024 | 8.665 | 54.583 | 110.762 | 136.294 | 149.98 | 225.002 |
Working Capital Per Share | 74.335 | 93.687 | 113.657 | 200.123 | 267.568 | 322.104 | 402.565 | 463.942 |
Operating Profit Per Share | 30.093 | 38.66 | 49.191 | 82.459 | 154.258 | 129.067 | 221.264 | 245.902 |
EBIT Per Share | 18.728 | 17.385 | 26.212 | 43.934 | 90.074 | 60.607 | 106.652 | 85.312 |
EBITDA Per Share | 18.728 | 17.385 | 26.212 | 43.934 | 90.074 | 60.607 | 106.652 | 85.312 |
Free Cash Flow Per Share | 19.54 | 18.342 | 30.274 | 32.424 | 73.521 | 45.802 | 84.124 | 66.606 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 60,35M | 61,19M | 61,5M | 65,08M | 65,55M | 65,72M | 65,96M | 66,08M |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
Actions en circulation | 65,96M | 65,99M | 66,04M | 66,07M | 66,08M | 66,12M | 66,14M | 66,18M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 10.231 | N/A | N/A | N/A | 41.588 | N/A | N/A |
Net Profit Margin (%) | N/A | 7.919 | N/A | N/A | N/A | 31.982 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 13,99B |
Ratio cours/bénéfice | 32,29 |
Ratio prix/ventes | 8,53 |
Ratio prix/liquidités | 9,45 |
Ratio prix/valeur comptable | 4,45 |
Rendement de dividende | - |
Actions en circulation | 660,75M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales